Literature DB >> 3725432

Primary cerebral neuroblastomas. A clinicopathological study of one adolescent and five adult patients.

V J Ojeda, B A Stokes, M A Lee, G W Thomas, J M Papadimitriou, L A Cala, S M Stevens, P O'Neill.   

Abstract

Neuronal differentiation was demonstrated by light microscopy, immunohistochemistry and electron microscopy in the cerebral neoplasms of one adolescent and five adult patients. The tumours exhibited a wide spectrum of cellular differentiation from low to high grade malignancy which seems to correlate well with their biological behaviour. The natural history of these 6 cerebral neuroblastomas is rather long compared to that of other malignant primary cerebral neoplasms of adulthood; however, 2 patients died, one survived about 5 yr after initial symptoms whilst an untreated patient survived more than 12 yr. It is suggested that morphological grading along the lines of Kernohan's system may be useful in determining the prognosis and postoperative management of patients with cerebral neuroblastomas.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3725432     DOI: 10.3109/00313028609090826

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  3 in total

1.  Patterns of differentiation in central neurocytoma. An immunohistochemical study of eleven biopsies.

Authors:  A von Deimling; R Janzer; P Kleihues; O D Wiestler
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

2.  Hypothalamic neurocytoma with vasopressin immunoreactivity: Immunohistochemical and ultrastructural observations.

Authors:  John A Maguire; Juan M Bilbao; Kaiman Kovacs; Lothar Resch
Journal:  Endocr Pathol       Date:  1992-06       Impact factor: 3.943

3.  Central neurocytoma: immunohistochemical and ultrastructural study.

Authors:  T Kubota; M Hayashi; H Kawano; M Kabuto; K Sato; J Ishise; K Kawamoto; K Shirataki; H Iizuka; S Tsunoda
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.